DK1492521T3 - Kombineret brug af L-carnitin, acetyl-L-carnitin og propionyl-L-carnitin i behandling af oligoasthenoteratospermi - Google Patents

Kombineret brug af L-carnitin, acetyl-L-carnitin og propionyl-L-carnitin i behandling af oligoasthenoteratospermi

Info

Publication number
DK1492521T3
DK1492521T3 DK03720869.1T DK03720869T DK1492521T3 DK 1492521 T3 DK1492521 T3 DK 1492521T3 DK 03720869 T DK03720869 T DK 03720869T DK 1492521 T3 DK1492521 T3 DK 1492521T3
Authority
DK
Denmark
Prior art keywords
carnitine
propionyl
acetyl
oligoasthenoteratospermia
treatment
Prior art date
Application number
DK03720869.1T
Other languages
English (en)
Inventor
Giorgio Cavallini
Giulio Biagiotti
Aleardo Koverech
Francesca Sardelli
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1492521T3 publication Critical patent/DK1492521T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK03720869.1T 2002-04-09 2003-04-08 Kombineret brug af L-carnitin, acetyl-L-carnitin og propionyl-L-carnitin i behandling af oligoasthenoteratospermi DK1492521T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000194A ITRM20020194A1 (it) 2002-04-09 2002-04-09 Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
PCT/IT2003/000214 WO2003084526A1 (en) 2002-04-09 2003-04-08 Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia

Publications (1)

Publication Number Publication Date
DK1492521T3 true DK1492521T3 (da) 2010-11-22

Family

ID=11456235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03720869.1T DK1492521T3 (da) 2002-04-09 2003-04-08 Kombineret brug af L-carnitin, acetyl-L-carnitin og propionyl-L-carnitin i behandling af oligoasthenoteratospermi

Country Status (20)

Country Link
US (2) US20050107470A1 (da)
EP (1) EP1492521B1 (da)
JP (1) JP4663987B2 (da)
KR (1) KR20040098005A (da)
CN (1) CN1330301C (da)
AT (1) ATE476974T1 (da)
AU (1) AU2003224443B2 (da)
BR (1) BR0309055A (da)
CA (1) CA2478674C (da)
CY (1) CY1111273T1 (da)
DE (1) DE60333742D1 (da)
DK (1) DK1492521T3 (da)
ES (1) ES2350338T3 (da)
HK (1) HK1078460A1 (da)
IT (1) ITRM20020194A1 (da)
MX (1) MXPA04009763A (da)
PL (1) PL214859B1 (da)
PT (1) PT1492521E (da)
SI (1) SI1492521T1 (da)
WO (1) WO2003084526A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ES2587977T3 (es) 2009-05-01 2016-10-28 Celloxess Llc Tratamiento de la infertilidad masculina secundaria al estrés oxidativo de esperma
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CN108041588A (zh) * 2017-12-08 2018-05-18 冯纪敏 一种含有海藻糖的组合物及其应用
CN109999042B (zh) * 2019-05-16 2021-05-18 北京华睿鼎信科技有限公司 包含脱氢表雄酮或其硫酸酯、左卡尼汀、乙酰左卡尼汀或它们的可药用盐的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1249462B (it) * 1991-10-21 1995-02-23 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche.
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
GB9721746D0 (en) 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
ITRM20010029A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
ITRM20020055A1 (it) 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti

Also Published As

Publication number Publication date
EP1492521B1 (en) 2010-08-11
KR20040098005A (ko) 2004-11-18
SI1492521T1 (sl) 2010-12-31
CA2478674C (en) 2010-10-19
ITRM20020194A0 (it) 2002-04-09
ITRM20020194A1 (it) 2003-10-09
BR0309055A (pt) 2005-02-22
CY1111273T1 (el) 2015-08-05
AU2003224443A1 (en) 2003-10-20
CN1330301C (zh) 2007-08-08
US20090012169A1 (en) 2009-01-08
US20050107470A1 (en) 2005-05-19
CN1638754A (zh) 2005-07-13
PL214859B1 (pl) 2013-09-30
EP1492521A1 (en) 2005-01-05
CA2478674A1 (en) 2003-10-16
DE60333742D1 (de) 2010-09-23
HK1078460A1 (en) 2006-03-17
ATE476974T1 (de) 2010-08-15
AU2003224443B2 (en) 2008-09-11
US8415392B2 (en) 2013-04-09
WO2003084526A1 (en) 2003-10-16
JP2006505499A (ja) 2006-02-16
PT1492521E (pt) 2010-11-11
PL372924A1 (en) 2005-08-08
MXPA04009763A (es) 2004-12-13
ES2350338T3 (es) 2011-01-21
JP4663987B2 (ja) 2011-04-06

Similar Documents

Publication Publication Date Title
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
DE60209504D1 (de) Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
EA201391705A1 (ru) Триазолпиридиновые ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i
NO20061291L (no) Ny formulering
NO20062699L (no) Smelteblandingsdispergeringer
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
NO20043984L (no) Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler
HK1078460A1 (en) Use of l-carnitine, actyl l-carnitine and propionyl l-carnitine in the manufacture of a combined medicament for the treatment of oligoasthenoteratospermia
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
MXPA05009282A (es) Derivados de anilina sustituidos.
NO20052582D0 (no) Framgangsmate og anlegg for avsalting av saltholdig vann.
DK1562577T3 (da) Acetyl-L-carnitin til forebyggelse og/eller behandling af perifere neuropatier, der induceres af anticancermidler
AR024981A1 (es) Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon
RU2002103550A (ru) Способ фотообеззараживания воды
DE60325079D1 (de) Naphthamidderivate und deren verwendung
PT1399142E (pt) Utilizacao de acetil-l-carnitina em associacao com biotina para o tratamento de doentes com diabetes mellitus insulino-resistente do tipo 2
DK1811988T3 (da) Anvendelse af acetyl-L-carnitin i kombination med propionyl-L-carnitin og sildenafil til behandling af erektil dysfunktion
NO20062700L (no) Morfolinderivater som norepinefrin reopptaksinhibitorer
DK1373249T3 (da) Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel
PT1937245E (pt) Composto útil para a prevenção e o tratamento de hipertrofia ventricular esquerda em pacientes dialisados
GEP20074194B (en) Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid
DK1824472T3 (da) Anvendelse af acetyl L-carnitin til behandling af fibromyalgisyndrom
EG25373A (en) Local natural product in treatment of psoriasis.